30 August 2022 - The European Commission, the Heads of Medicines Agencies and the EMA have published the 2022-2026 workplan of the initiative Accelerating Clinical Trials in the EU (ACT EU).
ACT EU, launched in January 2022, seeks to transform how clinical trials are initiated, designed and run.